+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
JUBLINGREA

Jubilant Ingrevia Share Price

₹735.70 +7.25 (1%)
36.93% Gain from 52W Low

31 Jul, 2026 3:52 PM (IST)

Jubilant Ingrevia live price: ₹735.70. It opened at ₹735 vs previous close ₹728; intraday high/low: ₹740/₹726. The 50 & 200 DMA stand at ₹696.70/₹677.00.

Jubilant Ingrevia Performance

  • Today's Low
  • ₹726
  • Today's High
  • ₹740
  • 52 Week Low
  • ₹537
  • 52 Week High
  • ₹799
  • Open Price₹735
  • Previous Close₹728
  • Volume141,992
  • 50 DMA₹696.70
  • 100 DMA₹681.20
  • 200 DMA₹677.00

Jubilant Ingrevia Chart

Investment Returns

  • Over 1 Month + 20.96%
  • Over 3 Month + 3.08%
  • Over 6 Month + 15.81%
  • Over 1 Year -6%

Smart Investing Starts Here Start SIP with Jubilant Ingrevia for Steady Growth!

Invest Now

Jubilant Ingrevia Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 38
  • PEG Ratio
  • 3.4
  • Market Cap Cr
  • 11,718
  • P/B Ratio
  • 3.7
  • Average True Range
  • 25.8
  • EPS
  • 19.4
  • Dividend Yield
  • 0.7
  • MACD Signal
  • 17
  • RSI
  • 56.45
  • MFI
  • 25.12

Latest Stock News Updates

Jubilant Ingrevia Ltd - 543271 - Intimation Regarding Letter Dispatched To The Shareholders Of The Company For Annual Report Of The Company For FY 2025-26

Letter sent to the shareholders whose e-mails are not registered

Jubilant Ingrevia Ltd - 543271 - Communication Sent To The Shareholders Regarding Deduction Of Tax At Source (TDS) On Final Dividend For FY 2025-26

Communication sent to shareholders regarding TDS on the Final Dividend for the FY 2025-26

Jubilant Ingrevia Ltd - 543271 - Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report of the Company for the Financial Year 2025-26

Jubilant Ingrevia Financials

Jubilant Ingrevia Technicals

EMA & SMA

Current Price
₹735.70
+ 7.25 (1%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹721.80
  • 50 Day
  • ₹696.70
  • 100 Day
  • ₹681.20
  • 200 Day
  • ₹677.00

Resistance and Support

733.97 Pivot Speed
  • R3 755.50
  • R2 747.70
  • R1 741.70
  • S1 728.00
  • S2 720.20
  • S3 714.20

Jubilant Ingrevia Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-22 Quarterly Results
2026-05-26 Audited Results & Final Dividend
2026-02-04 Quarterly Results
2025-10-27 Quarterly Results
2025-07-31 Quarterly Results
Date Purpose Remarks
2026-07-24 FINAL Rs.2.50 per share(250%)Final Dividend
2026-02-10 INTERIM Rs.2.50 per share(250%)Interim Dividend
2025-07-25 FINAL Rs.2.50 per share(250%)Final Dividend
2025-02-03 INTERIM Rs.2.50 per share(250%)Interim Dividend
2024-08-02 FINAL Rs.2.50 per share(250%)Final Dividend
View Jubilant Ingrevia Dividend History Arrow

Jubilant Ingrevia Shareholding Pattern

45.22%
22.39%
22.3%
6.49%
2.61%

About Jubilant Ingrevia

Jubilant Ingrevia The Group is a global integrated life science products and innovative solutions provider serving, pharmaceutical, nutrition, agrochemical, consumer and industrial customers with its customised products and solutions that are innovative, View More
  • NSE Symbol
  • JUBLINGREA
  • BSE Symbol
  • 543271
  • Executive Director,Managing Director,Chief Executive Officer
  • Mr. Deepak Jain
  • ISIN
  • INE0BY001018

Similar Stocks to Jubilant Ingrevia

Jubilant Ingrevia FAQs

Jubilant Ingrevia share price is ₹735 As on 02 August, 2026 | 03:37

The Market Cap of Jubilant Ingrevia is ₹11718.3 Cr As on 02 August, 2026 | 03:37

The P/E ratio of Jubilant Ingrevia is 38 As on 02 August, 2026 | 03:37

The PB ratio of Jubilant Ingrevia is 3.7 As on 02 August, 2026 | 03:37

The 52 week High & Low of Jubilant Ingrevia is ₹799/₹537.3 respectively As on 02 August, 2026 | 03:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23